1. Home
  2. KZIA vs RUBI Comparison

KZIA vs RUBI Comparison

Compare KZIA & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • RUBI
  • Stock Information
  • Founded
  • KZIA 1994
  • RUBI N/A
  • Country
  • KZIA Australia
  • RUBI Marshall Islands
  • Employees
  • KZIA N/A
  • RUBI N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • RUBI Marine Transportation
  • Sector
  • KZIA Health Care
  • RUBI Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • RUBI Nasdaq
  • Market Cap
  • KZIA 9.0M
  • RUBI 8.9M
  • IPO Year
  • KZIA 1999
  • RUBI N/A
  • Fundamental
  • Price
  • KZIA $7.94
  • RUBI $2.47
  • Analyst Decision
  • KZIA Strong Buy
  • RUBI
  • Analyst Count
  • KZIA 2
  • RUBI 0
  • Target Price
  • KZIA $14.00
  • RUBI N/A
  • AVG Volume (30 Days)
  • KZIA 137.3K
  • RUBI 44.8K
  • Earning Date
  • KZIA 11-14-2025
  • RUBI 05-06-2020
  • Dividend Yield
  • KZIA N/A
  • RUBI N/A
  • EPS Growth
  • KZIA N/A
  • RUBI N/A
  • EPS
  • KZIA N/A
  • RUBI N/A
  • Revenue
  • KZIA $1,549,158.00
  • RUBI N/A
  • Revenue This Year
  • KZIA N/A
  • RUBI N/A
  • Revenue Next Year
  • KZIA $49.25
  • RUBI N/A
  • P/E Ratio
  • KZIA N/A
  • RUBI N/A
  • Revenue Growth
  • KZIA 248983.08
  • RUBI N/A
  • 52 Week Low
  • KZIA $2.86
  • RUBI $2.32
  • 52 Week High
  • KZIA $39.05
  • RUBI $6.69
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 48.43
  • RUBI N/A
  • Support Level
  • KZIA $7.60
  • RUBI N/A
  • Resistance Level
  • KZIA $8.28
  • RUBI N/A
  • Average True Range (ATR)
  • KZIA 0.51
  • RUBI 0.00
  • MACD
  • KZIA 0.03
  • RUBI 0.00
  • Stochastic Oscillator
  • KZIA 30.88
  • RUBI 0.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About RUBI Rubico Inc. Common Stock

Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.

Share on Social Networks: